Major pathways of the reno-cardiovascular link

The sympathetic and renin-angiotensin systems

Peter J. Blankestijn, Gerard London, Danilo Fliser, Kitty J. Jager, Bengt Lindholm, David Goldsmith, Andrzej Wiecek, Gultekin Suleymanlar, Rajiv Agarwal, Alberto Ortiz, Ziad Massy, Alberto Martinez-Castelao, Adrian Covic, Friedo W. Dekker, Carmine Zoccali

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Chronic kidney disease is often characterized by enhanced activity of the renin-angiotensin system (RAS) and the sympathetic nervous system. Independent of their effect on blood pressure, these systems also contribute to the pathogenesis of both structural and functional cardiovascular abnormalities and contribute importantly to clinical outcome. There is much evidence that the diseased kidneys are of central importance in the pathogenesis of both abnormalities. Inhibitors of the RAS also reduce sympathetic overactivity. Future research should be aimed at addressing the pathophysiological mechanisms causing the enhanced activities. Given the fact that even a small kidney lesion can cause enhanced activity of the RAS and the sympathetic nervous system, it is likely that these pathophysiological mechanisms are operational in more disease conditions, including essential hypertension, heart failure, and obesity/metabolic syndrome.

Original languageEnglish
Pages (from-to)13-16
Number of pages4
JournalKidney International Supplements
Volume1
Issue number1
DOIs
StatePublished - Jun 2011

Fingerprint

Renin-Angiotensin System
Sympathetic Nervous System
Cardiovascular Abnormalities
Kidney Diseases
Chronic Renal Insufficiency
Heart Failure
Obesity
Blood Pressure
Kidney

Keywords

  • chronic kidney disease
  • hypertension
  • renin angiotensin
  • sympathetic activity

ASJC Scopus subject areas

  • Nephrology

Cite this

Blankestijn, P. J., London, G., Fliser, D., Jager, K. J., Lindholm, B., Goldsmith, D., ... Zoccali, C. (2011). Major pathways of the reno-cardiovascular link: The sympathetic and renin-angiotensin systems. Kidney International Supplements, 1(1), 13-16. https://doi.org/10.1038/kisup.2011.3

Major pathways of the reno-cardiovascular link : The sympathetic and renin-angiotensin systems. / Blankestijn, Peter J.; London, Gerard; Fliser, Danilo; Jager, Kitty J.; Lindholm, Bengt; Goldsmith, David; Wiecek, Andrzej; Suleymanlar, Gultekin; Agarwal, Rajiv; Ortiz, Alberto; Massy, Ziad; Martinez-Castelao, Alberto; Covic, Adrian; Dekker, Friedo W.; Zoccali, Carmine.

In: Kidney International Supplements, Vol. 1, No. 1, 06.2011, p. 13-16.

Research output: Contribution to journalArticle

Blankestijn, PJ, London, G, Fliser, D, Jager, KJ, Lindholm, B, Goldsmith, D, Wiecek, A, Suleymanlar, G, Agarwal, R, Ortiz, A, Massy, Z, Martinez-Castelao, A, Covic, A, Dekker, FW & Zoccali, C 2011, 'Major pathways of the reno-cardiovascular link: The sympathetic and renin-angiotensin systems', Kidney International Supplements, vol. 1, no. 1, pp. 13-16. https://doi.org/10.1038/kisup.2011.3
Blankestijn, Peter J. ; London, Gerard ; Fliser, Danilo ; Jager, Kitty J. ; Lindholm, Bengt ; Goldsmith, David ; Wiecek, Andrzej ; Suleymanlar, Gultekin ; Agarwal, Rajiv ; Ortiz, Alberto ; Massy, Ziad ; Martinez-Castelao, Alberto ; Covic, Adrian ; Dekker, Friedo W. ; Zoccali, Carmine. / Major pathways of the reno-cardiovascular link : The sympathetic and renin-angiotensin systems. In: Kidney International Supplements. 2011 ; Vol. 1, No. 1. pp. 13-16.
@article{5578952ba4444117ae871a4a334a5bec,
title = "Major pathways of the reno-cardiovascular link: The sympathetic and renin-angiotensin systems",
abstract = "Chronic kidney disease is often characterized by enhanced activity of the renin-angiotensin system (RAS) and the sympathetic nervous system. Independent of their effect on blood pressure, these systems also contribute to the pathogenesis of both structural and functional cardiovascular abnormalities and contribute importantly to clinical outcome. There is much evidence that the diseased kidneys are of central importance in the pathogenesis of both abnormalities. Inhibitors of the RAS also reduce sympathetic overactivity. Future research should be aimed at addressing the pathophysiological mechanisms causing the enhanced activities. Given the fact that even a small kidney lesion can cause enhanced activity of the RAS and the sympathetic nervous system, it is likely that these pathophysiological mechanisms are operational in more disease conditions, including essential hypertension, heart failure, and obesity/metabolic syndrome.",
keywords = "chronic kidney disease, hypertension, renin angiotensin, sympathetic activity",
author = "Blankestijn, {Peter J.} and Gerard London and Danilo Fliser and Jager, {Kitty J.} and Bengt Lindholm and David Goldsmith and Andrzej Wiecek and Gultekin Suleymanlar and Rajiv Agarwal and Alberto Ortiz and Ziad Massy and Alberto Martinez-Castelao and Adrian Covic and Dekker, {Friedo W.} and Carmine Zoccali",
year = "2011",
month = "6",
doi = "10.1038/kisup.2011.3",
language = "English",
volume = "1",
pages = "13--16",
journal = "Kidney International Supplements",
issn = "2157-1724",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Major pathways of the reno-cardiovascular link

T2 - The sympathetic and renin-angiotensin systems

AU - Blankestijn, Peter J.

AU - London, Gerard

AU - Fliser, Danilo

AU - Jager, Kitty J.

AU - Lindholm, Bengt

AU - Goldsmith, David

AU - Wiecek, Andrzej

AU - Suleymanlar, Gultekin

AU - Agarwal, Rajiv

AU - Ortiz, Alberto

AU - Massy, Ziad

AU - Martinez-Castelao, Alberto

AU - Covic, Adrian

AU - Dekker, Friedo W.

AU - Zoccali, Carmine

PY - 2011/6

Y1 - 2011/6

N2 - Chronic kidney disease is often characterized by enhanced activity of the renin-angiotensin system (RAS) and the sympathetic nervous system. Independent of their effect on blood pressure, these systems also contribute to the pathogenesis of both structural and functional cardiovascular abnormalities and contribute importantly to clinical outcome. There is much evidence that the diseased kidneys are of central importance in the pathogenesis of both abnormalities. Inhibitors of the RAS also reduce sympathetic overactivity. Future research should be aimed at addressing the pathophysiological mechanisms causing the enhanced activities. Given the fact that even a small kidney lesion can cause enhanced activity of the RAS and the sympathetic nervous system, it is likely that these pathophysiological mechanisms are operational in more disease conditions, including essential hypertension, heart failure, and obesity/metabolic syndrome.

AB - Chronic kidney disease is often characterized by enhanced activity of the renin-angiotensin system (RAS) and the sympathetic nervous system. Independent of their effect on blood pressure, these systems also contribute to the pathogenesis of both structural and functional cardiovascular abnormalities and contribute importantly to clinical outcome. There is much evidence that the diseased kidneys are of central importance in the pathogenesis of both abnormalities. Inhibitors of the RAS also reduce sympathetic overactivity. Future research should be aimed at addressing the pathophysiological mechanisms causing the enhanced activities. Given the fact that even a small kidney lesion can cause enhanced activity of the RAS and the sympathetic nervous system, it is likely that these pathophysiological mechanisms are operational in more disease conditions, including essential hypertension, heart failure, and obesity/metabolic syndrome.

KW - chronic kidney disease

KW - hypertension

KW - renin angiotensin

KW - sympathetic activity

UR - http://www.scopus.com/inward/record.url?scp=84884399850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884399850&partnerID=8YFLogxK

U2 - 10.1038/kisup.2011.3

DO - 10.1038/kisup.2011.3

M3 - Article

VL - 1

SP - 13

EP - 16

JO - Kidney International Supplements

JF - Kidney International Supplements

SN - 2157-1724

IS - 1

ER -